| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |